U.S. Markets open in 40 mins.

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
6.01-0.06 (-0.99%)
At close: 4:00PM EDT
People also watch
SGENIMMUEXELINCYCLDX
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue6/30/20166/30/20156/30/2014
Total Revenue60,00285,54159,896
Cost of Revenue---
Gross Profit60,00285,54159,896
Operating Expenses
Research Development148,077111,768106,958
Selling General and Administrative36,91628,22824,469
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-124,991-54,455-71,531
Income from Continuing Operations
Total Other Income/Expenses Net-19,826-6,284167
Earnings Before Interest and Taxes-144,817-60,739-71,364
Interest Expense---
Income Before Tax-144,817-60,739-71,364
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-144,817-60,739-71,364
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-144,817-60,739-71,364
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-144,817-60,739-71,364